UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000593
Receipt number R000000675
Scientific Title Randomized controlled trial of mizoribine for progressive IgA nephropathy
Date of disclosure of the study information 2007/02/05
Last modified on 2018/09/21 08:13:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized controlled trial of
mizoribine for progressive IgA
nephropathy

Acronym

Randomized controlled trial of mizoribine for progressive IgA nephropathy

Scientific Title

Randomized controlled trial of
mizoribine for progressive IgA
nephropathy

Scientific Title:Acronym

Randomized controlled trial of mizoribine for progressive IgA nephropathy

Region

Japan


Condition

Condition

IgA nephropathy with moderate to severe histological alterations

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism
Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Investigation of efficacy and safety of mizoribine for IgA nephropathy with moderate to severe histological alterations

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Altered amounts of proteinuria

Key secondary outcomes

Alteration of serum creatinine (SCr) and the slope of reciprocal SCr


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Methylprednisolone pulse therapy followed by oral prednisolone administration

Interventions/Control_2

Methylprednisolone pulse therapy followed by oral prednisolone and mizoribine administration

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Patients with IgA nephropathy who underwent renal biopsy and provided a written informed consent prior to study by reading and signing the form.
1) Patients who have 5 or more of glomerular score*.
2) Patients who are between 15 and 60 years of age.
3) Patients who have potential to receive methylprednisolone pulse therapy on inpatient basis, and thereafter to receive routine medical treatment as outpatients.
*(Katafuchi R et al.Clin Nephrol 49,1998)

Key exclusion criteria

1) Patients who have been treated with corticosteroids or mizoribine already
2) Patients who suffered infectious diseases such as pneumonia
3) Patients whose white blood cells count is under 3,000/mm3
4) Patients who are demonstrated to have another renal disease on renal biopsy
5) Patients who have diabetes mellitus
6) Patients who are have severe heart or liver disease
7) Patients who have malignant tumors
8) Patients who are currently pregnant or are supposed to be pregnant
9) Patients who are judged to be inappropriate for participation in this study by an physician

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kazuhiko Tsuruya

Organization

Graduate School of Medical Sciences, Kyushu University

Division name

Department of Integrated Therapy for Chronic Kidney Disease

Zip code


Address

Maidashi 3-1-1, Higashi-ku, Fukuoka

TEL

092-642-5843

Email

tsuruya@intmed2.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kosuke Masutani

Organization

West Japan Study Group for Therapy of IgA Nephropathy

Division name

Kidney Care Unit, Kyushu University Hospital

Zip code


Address

Maidashi 3-1-1, Higashi-ku, Fukuoka

TEL

092-642-5843

Homepage URL


Email

masutani@kcu.med.kyushu-u.ac.jp


Sponsor or person

Institute

West Japan Study Group for Therapy of IgA Nephropathy

Institute

Department

Personal name



Funding Source

Organization

The Kidney Foundation, Japan

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 02 Month 05 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications

https://www.ncbi.nlm.nih.gov/pubmed/26758039

Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2006 Year 11 Month 01 Day

Last follow-up date

2010 Year 10 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2007 Year 02 Month 05 Day

Last modified on

2018 Year 09 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000675


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name